Assignee
OSE IMMUNOTHERAPEUTICS
FR24 patents
Top patents by PatentIndex Score
US11440964B2Sep 13, 2022
Method for treating a pathological condition involving the activation or proliferation of CD127 positive cells with an anti-CD127 antibody
OSE IMMUNOTHERAPEUTICS2 citations72
US11230602B2Jan 25, 2022
Non-antagonistic antibodies directed against the alpha chain of the IL7 receptor extracellular domain and use thereof in cancer treatment
OSE IMMUNOTHERAPEUTICS2 citations72
US10428152B2Oct 1, 2019
Antibodies directed against CD127
OSE IMMUNOTHERAPEUTICS3 citations72
US10364287B2Jul 30, 2019
Anti-CD28 humanized antibodies
OSE IMMUNOTHERAPEUTICS3 citations72
US11191820B2Dec 7, 2021
Method for inducing early T memory response with short peptides anti-tumor vaccine
OSE IMMUNOTHERAPEUTICS2 citations71
US10434157B2Oct 8, 2019
Therapeutic multi-peptides T specific immune therapy for treatment of brain metastasis
OSE IMMUNOTHERAPEUTICS3 citations71
US11279766B2Mar 22, 2022
Anti-SIRPa antibodies and their therapeutic applications
OSE IMMUNOTHERAPEUTICS3 citations70
US11352430B2Jun 7, 2022
Humanized anti-human-PD-1 antibody and its use in cancer treatment
OSE IMMUNOTHERAPEUTICS2 citations68
US11325959B2May 10, 2022
Method for manufacturing a stable emulsion for peptide delivery
OSE IMMUNOTHERAPEUTICS2 citations63
US12371502B2Jul 29, 2025
Antibodies directed against CD127
OSE IMMUNOTHERAPEUTICS0 citations62
US11926671B2Mar 12, 2024
Antibodies and polypeptides directed against CD127
OSE IMMUNOTHERAPEUTICS0 citations61
US11098128B2Aug 24, 2021
Antibodies and polypeptides directed against CD127
OSE IMMUNOTHERAPEUTICS1 citations61
US12331115B2Jun 17, 2025
Uses of anti-SIRPg antibodies
OSE IMMUNOTHERAPEUTICS0 citations59
US12252546B2Mar 18, 2025
Anti-SIRPa antibodies and their therapeutic applications
OSE IMMUNOTHERAPEUTICS0 citations59
US12331118B2Jun 17, 2025
Humanized anti-human-PD-1 antibody and methods of using them for cancer treatment
OSE IMMUNOTHERAPEUTICS0 citations57
US12534533B2Jan 27, 2026
Anti-chemokine like receptor 1 humanized antibodies and their therapeutic applications
OSE IMMUNOTHERAPEUTICS0 citations56
US11981713B2May 14, 2024
Method for manufacturing a stable emulsion for peptide delivery
OSE IMMUNOTHERAPEUTICS0 citations53
US11713356B2Aug 1, 2023
Modified bifunctional anti-human signal regulatory protein alpha (SIRPa) antibody and method of use thereof for treating cancer
OSE IMMUNOTHERAPEUTICS0 citations51
US11696936B2Jul 11, 2023
Treatment of cancer
OSE IMMUNOTHERAPEUTICS0 citations50
US11884723B2Jan 30, 2024
Use of anti-human SIRPa v1 antibodies and method for producing anti-SIRPa v1 antibodies
OSE IMMUNOTHERAPEUTICS0 citations49
US12077820B2Sep 3, 2024
Biomarkers for assessing the response status for treatment of Inflammatory condition or disease affecting the digestive tract such as inflammatory bowel disease in human patients
OSE IMMUNOTHERAPEUTICS0 citations48
US10689444B2Jun 23, 2020
Recombinant monovalent antibodies
OSE IMMUNOTHERAPEUTICS0 citations47
US12448454B2Oct 21, 2025
Humanized anti-CLEC-1A antibodies and antigen-binding fragments thereof
OSE IMMUNOTHERAPEUTICS0 citations45
US12258577B2Mar 25, 2025
Method effector cells using anti-CD127 antibodies for applications in cell therapy
OSE IMMUNOTHERAPEUTICS0 citations43